Ignacio Moraga Gonzalez
7Patents
1h-index
11Co-inventors
44Inventor score
Filing activity: May 20, 2005 → Jul 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9512194B2 | Modified IL-13 polypeptides | Physics | 12 | Active |
| US12419954B2 | Targeted chimeric antigen receptor modified T cells for treatment of IL13Rα2 positive malignancies | Human Necessities | 0 | Active |
| US9732133B2 | Therapeutic IL-13 polypeptides | Physics | 0 | Active |
| US10227389B2 | Therapeutic IL-13 polypeptides | Physics | 0 | Active |
| US11993639B2 | Therapeutic IL-13 polypeptides | Physics | 0 | Active |
| US7807445B2 | Antibiotic compound | Emerging Cross-Sectional Technologies | 0 | Active |
| US11084858B2 | Therapeutic IL-13 polypeptides | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.